The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s hospital acquired infections testing kits market report forecasts the hospital acquired infections testing kits market size to grow to $2 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Hospital Acquired Infections Testing Kits Market Report 2023 – https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

Hospital Acquired Infections Testing Kits Market Size Forecast

The global hospital acquired infections testing kits market is expected to grow from $1.27 billion in 2022 to $1.4 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hospital acquired infections testing kits market is expected to grow from $2 billion in 2027 at a CAGR of 9.4%.

North America held the largest hospital acquired infections testing kits market share.

Key Hospital Acquired Infections Testing Kits Market Driver ­– Increase In The Demand For Both The Inpatients And Outpatients

For example, according to the findings by the Center for Disease Control and Prevention, around 1.7 million people in the USA acquire hospital-acquired infections caused while being admitted for other health issues and more than 98,000 (around 5%) patients die due to these infections. The increasing incidence of hospital-acquired infections leads to an increase in the demand for hospital-acquired infections testing kits.

Request for A Sample Of The Global Hospital Acquired Infections Testing Kits Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

Key Hospital Acquired Infections Testing Kits Market Trend – Advancing Nucleic Acid-Based Technologies

The diagnostic tests involved in diagnosing HAIs such as flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based technologies are advancing in technologies, providing more accurate data. There has been a significant advancement in mass spectrometers, which quantifies known materials, and identifies unknown compounds within a sample. For instance, SCIEX’s X500 QTOF solves the challenge of contamination and is a compact device that does not compromise on resolution and accuracy. It gives results sooner and allows the operator to make data-driven decisions sooner.

Hospital Acquired Infections Testing Kits Market Segment

1) By Product: Instrument & Reagents, Consumables

2) By Test Type: Pneumonia Infection, Urinary Tract Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA Infection, Other Test Types

3) By Application: Drug-resistance Testing, Disease Testing

4) By Pathogen Type: Viral, Bacterial, Fungal

5) By Method of Treatment: Sterilization, Chemical, Radiation

Hospital Acquired Infections Testing Kits Market Major Players and Strategies

Major players in the hospital acquired infections testing kits market are Becton, Dickinson and Company, Abott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd., Hologic, Roche, Bayer AG, Cantel Medical Corporation, and Meridian Bioscience.

The Hospital Acquired Infections Testing Kits Global Market Report 2023 covers regional data on hospital acquired infections testing kits market size, hospital acquired infections testing kits market trends and drivers, opportunities, strategies, and hospital acquired infections testing kits market competitor analysis. The countries covered in the hospital acquired infections testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The hospital-acquired infection testing kits are tools used to check the infections people get while in a healthcare facility. Hospital-acquired infections testing kits are used to check the infections associated with pathogens such as vancomycin-resistant enterococci (VRE), methicillin-resistant staphylococcus aureus (MRSA), multi-resistant gram-negative bacilli, norovirus, and Clostridium difficile.

View More Reports Related To The Hospital Acquired Infections Testing Kits Market –

Hospital-Acquired Infection Control Global Market Report 2023

Pharmaceutical Sterility Testing Global Market Report 2023

Rapid Microbiology Testing Kits Global Market Report 2023

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: